Search results
1 – 10 of 520John Moriarty and Kathryn Higgins
The purpose of this paper is to capitalise on three waves of longitudinal data from a cohort of 4,351 secondary school pupils to examine the effects on individuals’ cannabis use…
Abstract
Purpose
The purpose of this paper is to capitalise on three waves of longitudinal data from a cohort of 4,351 secondary school pupils to examine the effects on individuals’ cannabis use uptake of both peer cannabis use and position within a peer network.
Design/methodology/approach
Both cross-sectional and individual fixed effects models are used to estimate the effect on cannabis use of nominated friends’ cannabis use, of reciprocity and transitivity of nominations across the friendship cluster, and of interactions between these nominated friends. Post hoc analyses parsed the behaviour of reciprocating and non-reciprocating friends.
Findings
Cannabis use varied depending on the stability of friendship network and the degree of reciprocity and interconnectedness within the group. Behavioural influence was strong, but interaction effects were observed between the prevalence of cannabis use among friends, the structure of the friendship group and ego’s proximity to group members. These interactions demonstrate that behavioural influence is more salient in more cohesive groups. When reciprocating and non-reciprocating friends’ mean cannabis use were separated, influence from reciprocating friends was estimated at twice the magnitude of other friends.
Originality/value
While preventing any one individual from using cannabis is likely to have a multiplier effect on classmates, the bonds and interactions between classmates will determine which classmates are affected by this multiplier and the salience of that effect.
Details
Keywords
Cannabis treatment entries rose significantly from 2004/2005 to 2013/2014, but there has been limited investigation into why this increase has occurred. The purpose of this paper…
Abstract
Purpose
Cannabis treatment entries rose significantly from 2004/2005 to 2013/2014, but there has been limited investigation into why this increase has occurred. The purpose of this paper is to evaluate the plausibility of different explanations within the English context and identifies gaps in the literature.
Design/methodology/approach
Explanations have been categorised under: misreporting, increased probability of entering treatment and increased incidence of cannabis use disorder (CUD). The explanations are evaluated through published literature, data in the public domain and interview data. Interview participants included four practitioners, one senior manager, one commissioner, one journalist, one academic and one clinician.
Findings
Plausible and influential explanations are that an expanding treatment offer occurred alongside an expanding cohort of people needing support for CUD. The evidence suggests increased prevalence in the 1990s to early 2000s, and an increase in high-potency cannabis, led to a significant rise in need for cannabis treatment. Minor explanations relating to funding formulas, criminal justice referrals and the emergence of synthetic cannabinoids could also cumulatively have a substantial effect on the data.
Research limitations/implications
Due to the dearth of research in use and attitudes towards cannabis, there are some explanations which cannot be ruled out.
Practical implications
More research is needed on user perceptions of cannabis harms and how intensively people are using cannabis.
Social implications
Wider implications are that a genuine and increasing need for support relating to cannabis within the English population requires an appropriate response from national bodies, commissioners and service providers.
Originality/value
A more comprehensive understanding of why this new cohort is emerging can inform better service provision and commissioning.
Details
Keywords
Aleksi Hupli, Ali Unlu, Jussi Jylkkä and Atte Oksanen
Cannabis use continues to increase worldwide, and a number of nation states are changing their cannabis policies. Policy changes require research into key populations, namely…
Abstract
Purpose
Cannabis use continues to increase worldwide, and a number of nation states are changing their cannabis policies. Policy changes require research into key populations, namely, people who use cannabis. This study aims to examine sociodemographic differences of young Finns who reported using cannabis mainly for self-medication versus mainly recreationally, as well as their reported effects of cannabis use.
Design/methodology/approach
The data come from an anonymous online survey (N = 247, 70.0% males, 25.9% females, 4.1% other) that was analysed using multiple logistic regression. The authors focused on whether various demographic indicators differed between those who reportedly used cannabis mainly for recreational purposes and mainly for self-medicinal purposes. The authors also qualitatively examined the respondents’ experienced effects of cannabis, both desired and undesired.
Findings
Being older and female, living in a smaller city and earlier age of initiation of cannabis use were statistically significant in predicting the medicinal use of cannabis. The majority of recreational effects were related to themes such as relaxation and pleasure, but many participants also reported desired medical effects. Similarly, many participants reported several undesired effects.
Research limitations/implications
Understanding especially young people’s motivations to use cannabis, which include using it for various medical effects, can improve the design of harm reduction and treatment programmes as well as enhance the well-being of people who use cannabis.
Originality/value
This study gives a nuanced account of sociodemographic factors and motivations of young people who use cannabis in Finland as well as the reported effects it has on them, which complements data from national drug surveys.
Details
Keywords
Gary R. Potter and Hattie Wells
This paper aims to consider the nature of cannabis-related harms under the UK’s Misuse of Drugs Act (MDA). Written for the specific context of this four-paper special section on…
Abstract
Purpose
This paper aims to consider the nature of cannabis-related harms under the UK’s Misuse of Drugs Act (MDA). Written for the specific context of this four-paper special section on 50 years of the MDA, it argues that the MDA may cause more harm than it prevents.
Design/methodology/approach
An opinion piece offering a structured overview of cannabis-related harms under prohibition. It summarises existing evidence of the ways in which prohibition may exacerbate existing – and create new – harms related to the production, distribution, use and control of cannabis.
Findings
The paper argues that prohibition of cannabis under the MDA may cause more harm than it prevents.
Originality/value
It has long been argued that the MDA does not accurately or fairly reflect the harms of the substances it prohibits, and much existing research points to different ways in which drug prohibition can itself be harmful. The originality of this paper lies in bringing together these arguments and developing a framework for analysing the contribution of prohibition to drug-related harm.
Details
Keywords
Whilst drug use appears to be common amongst university students, the purpose of this paper is to move beyond mere drug prevalence, and use the six dimensions of normalisation to…
Abstract
Purpose
Whilst drug use appears to be common amongst university students, the purpose of this paper is to move beyond mere drug prevalence, and use the six dimensions of normalisation to better understand the role and place drugs play in the lives of university students.
Design/methodology/approach
In total, 512 students completed a student lifestyle survey.
Findings
A differentiated normalisation is occurring amongst different student groups; the social supply of drugs is common, and some users are “drifting” into supply roles yet such acts are neutralised. Students are “drug literate” and have to navigate drugs, and their consumption, availability and marketing, as part of their everyday student life.
Practical implications
Student drug use is not homogenous and very little is known about the nuances and diversity of their use/non-use beyond prevalence data. Qualitative studies are needed to better understand the processes of differentiated normalisation and social supply.
Originality/value
This is the first study in the UK to use the six dimensions of normalisation amongst a sample of university students.
Details
Keywords
The purpose of this paper is to study vaporizers – especially the vape pen – as a new technology in cannabis use. Until now, almost all information on the use of vaporizers or…
Abstract
Purpose
The purpose of this paper is to study vaporizers – especially the vape pen – as a new technology in cannabis use. Until now, almost all information on the use of vaporizers or e-cigarettes for cannabis consumption has come from the internet, the popular press, and accounts by users, but not from the scientific literature. More research is needed.
Design/methodology/approach
Since scientific studies of the phenomenon are virtually non-existent, the author will also base his study on sociological reflections upon internet sites and articles published both in subcultural and mainstream media. The author will document a national estimate of the prevalence of vaping based on a recent population survey in Finland.
Findings
Vaping is an emerging trend in cannabis culture internationally. It has been seen as a healthier route of administration than traditional ways of smoking cannabis. Other images, created especially with the help of advanced high-tech machinery and stylish and fashionable designs for the vape pen, are aiming at being cool and easy to use. In Finland, 6 percent of cannabis users make regular use of a vaporizer, and around a quarter of users use one occasionally. A vape pen or e-cigarette was regularly used by 2.6 percent and occasionally by 9.1 percent of cannabis users.
Originality/value
The trend of increasing vaping and the use of new devices has not been properly recognized among researchers. The paper presents some original results from a national population survey.
Details
Keywords
The purpose of this paper is to explore the qualitative relationship between cannabis and the most commonly used antidepressant drugs known as selective serotonin reuptake…
Abstract
Purpose
The purpose of this paper is to explore the qualitative relationship between cannabis and the most commonly used antidepressant drugs known as selective serotonin reuptake inhibitor (SSRIs) through the narratives of depressed individuals who have used both drugs at one point during their lifetime. Despite their prevalence, depression, cannabis use, and SSRI use have not been previously studied together through the perspective of those who have experienced them. Using a exploratory approach, this paper investigates and compares the user experiences of these drugs.
Design/methodology/approach
Semi-structured interviews were conducted involving participants who were between the ages of 16–59 in the UK and have used both SSRIs and cannabis either simultaneously or at any point in their lives. Five interviews were conducted either via telephone or in person, and the method of analysis was an inductive approach which was inspired by grounded-theory.
Findings
While the two drugs were used by participants in order to relieve symptoms of depression, they were used for very different reasons and typically at different stages of their lives. Though participants did not state that the drugs were interchangeable for improving mood, their responses indicated that these drugs were viewed as two alternatives to alleviate symptoms of depression. Participants’ relationships with their doctors also played a crucial role and affected interviewees’ decisions to use either SSRIs or cannabis, as well as perceptions of the medical industry.
Social implications
This research shows the importance of doctor and patient interactions as they were crucial influences on patients’ decisions related to drugs. Participants’ experiences with SSRI and cannabis were subjective and varied, therefore, the value of personalised treatment (which may or may not include psychotropic drugs) is highlighted. These findings can help health practitioners gain a better understanding of the rationale of depressed patients in choosing treatments and thereby improve healthcare outcomes.
Originality/value
Given that depression is stigmatised, and cannabis use is both illegal and stigmatised, this paper examines the opinions of a difficult to reach population. Previous work involving cannabis, antidepressants and mood-elevating effects is primarily written with a biochemical or medical perspective which paid more focus on the efficacy of these drugs and had less emphasis on the beliefs of the users. This paper highlights the opinions of cannabis and SSRI users regarding these two drugs specifically, which had not been previously explored.
Details
Keywords
Niki Kiepek, Jonathan Harris, Brenda Beagan and Marisa Buchanan
The purpose of this paper is to explore the prevalence and patterns of substance use among Canadian social workers. With legalisation of can professional regulatory bodies are…
Abstract
Purpose
The purpose of this paper is to explore the prevalence and patterns of substance use among Canadian social workers. With legalisation of can professional regulatory bodies are pressed to consider implications of substance use for their members.
Design/methodology/approach
An online survey collected data about demographics and substance use prevalence and patterns. Statistical analysis involved pairwise comparisons, binary logistic regression models and logistic regression models to explore correlations between substance use and demographic and work-related variables.
Findings
Among the respondents (n=489), findings indicate that past-year use of cannabis (24.1 per cent), cocaine (4.5 per cent), ecstasy (1.4 per cent), amphetamines (4.3 per cent), hallucinogens (2.4 per cent), opioid pain relievers (21.0 per cent) and alcohol (83.1 per cent) are higher than the general Canadian population. Years of work experience and working night shift were significant predictors of total number of substances used in the past year. Use of a substance by a person when they were a student was highly correlated with use when they were a professional.
Research limitations/implications
Prevalence of substance use among social workers was found to be higher than the Canadian population; potential due to the anonymous nature of data collection.
Originality/value
This study has implications for social conceptualisations of professionalism and for decisions regarding professional regulation. Previous literature about substance use by professionals has focussed predominantly on implications for increased surveillance, monitoring, and disciplinary action. We contend that since substance use among professionals tends to be concealed, there may be exacerbated social misconceptions about degree of risk and when it is appropriate to intervene.
Details